Precision Oncology Academy 2026 in Malaysia
Analysis based on 8 articles · First reported Aug 03, 2026 · Last updated Aug 04, 2026
The event is a promotional and educational initiative by Gene Solutions, a private biotechnology company, and is unlikely to have a direct impact on public markets. It may enhance Gene Solutions' brand recognition and credibility in the precision oncology space, potentially supporting its commercial growth in the region.
Gene Solutions Malaysia hosted the Precision Oncology Academy 2026 on 25 July 2026 at the Sheraton Petaling Jaya Hotel under the theme 'Beyond Actionable'. The Academy brought together oncology experts from the United Arab Emirates, Singapore, Malaysia, the US, and Vietnam to discuss how insights from tumour DNA and RNA can reveal treatment opportunities, explain drug resistance, and translate into more confident treatment decisions. The event featured scientific lectures, multidisciplinary case discussions, and interactive workshops. Key topics included comprehensive genomic and transcriptomic profiling, liquid biopsy and circulating tumour DNA (ctDNA) analysis, minimal residual disease (MRD) monitoring, and the integration of artificial intelligence in precision oncology. The faculty was led by Prof. Dr. Ho Gwo Fuang of Curie Oncology and Prof. Dr. Darren Lim Wan-Teck of the SingHealth, with contributions from other international experts. The Academy is an extension of the K-CONNECT Platform and followed the K-CONNECT Summit 2026 in Vietnam. Gene Solutions aims to connect scientific advancement with clinical practice, making precision oncology more accessible to clinicians and patients.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard